A61P 19 - Drugs for skeletal disorders

Patents for A61P 19 - Drugs for skeletal disorders (81,981)
11/2011
11/02/2011	CN102008659B Chinese medicinal capsules for treating lumbar intervertebral disc protrusion
11/02/2011	CN102000305B Traditional Chinese medical preparation for treating gout
11/02/2011	CN102000231B Medicine composition for treating osteopathic diseases
11/02/2011	CN101961431B Ointment for treating bone fractures
11/02/2011	CN101703586B Medicament for treating rheumatism
11/02/2011	CN101693029B Oral preparation having improved bioavailability
11/02/2011	CN101647844B Vinegar milk essence micro effervescent granules and preparation method thereof
11/02/2011	CN101530598B Plaster used for hyperosteogeny
11/02/2011	CN101461911B Chinese medicine oral capsule for treating gout
11/02/2011	CN101160306B Benzimidazole compound
11/02/2011	CN101014708B Use of antisense oligonucleotides or sirna to suppress expression of eif-5a1
11/01/2011	US8049008 Reverse-turn mimetics and method relating thereto
11/01/2011	US8048991 Antibody to an integrin heterodimer and/or a subunit thereof
11/01/2011	US8048918 Treatment of hyperproliferative diseases
11/01/2011	US8048847 Derivatives of the IL-2 receptor gamma chain, their production and use
11/01/2011	US8048646 NELL peptide expression systems and bone formation activity of NELL peptide
11/01/2011	CA2473461C Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these
11/01/2011	CA2466418C Lipoxin a4 analogs
11/01/2011	CA2452056C Compositions of bioactive material particles dispersed in a continuous solid encapsulating material
11/01/2011	CA2446193C 1,4-disubstituted benzo-fused cycloalkyl urea compounds
11/01/2011	CA2409741C Tnf-.alpha. production inhibitors
11/01/2011	CA2337967C Recombinant uricase protein
11/01/2011	CA2176942C Bmp-12, bmp-13 and tendon-inducing compositions thereof
10/2011
10/27/2011	WO2011133637A2 Compounds and methods for kinase modulation, and indications therefor
10/27/2011	WO2011132826A1 Transdermal drug delivery system and pharmaceutical composition for preventing or treating bone diseases
10/27/2011	WO2011131026A1 Furo[3, 2-g]chromene compounds and uses thereof
10/27/2011	WO2011087769A3 Nutritional compositions and methods for optimizing dietary acid-base potential
10/27/2011	WO2011065800A3 Pyrimidine derivative, method for preparing same and pharmaceutical composition containing same
10/27/2011	WO2011056511A3 4,6-diaminopyrimidine stimulators of soluble guanylate cyclase
10/27/2011	US20110263721 Aryl di-substituted propenone compounds
10/27/2011	US20110263716 Colchine compositions and methods
10/27/2011	US20110263704 Methods of Using Cycloalkylmethylamines
10/27/2011	US20110263687 Rna molecules and uses thereof
10/27/2011	US20110263684 Lipid Formulated Compositions and Methods for Inhibiting Expression of Serum Amyloid A Gene
10/27/2011	US20110263675 Methods of modulating mesenchymal stem cell differentiation
10/27/2011	US20110263661 3-(4-((1h-imidazol-1-yl)methyl)phenyl)-5-aryl-1,2,4-oxadiazole derivatives as sphingosine-1 phosphate receptors modulators
10/27/2011	US20110263659 Analogs of 1-Methylnicotinamide
10/27/2011	US20110263656 Pirfenidone Treatment for Patients with Atypical Liver Function
10/27/2011	US20110263651 Novel piperidine-butyramide derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
10/27/2011	US20110263612 Compounds that modulate intracellular calcium
10/27/2011	US20110263610 Compounds and compositions as itpkb inhibitors
10/27/2011	US20110263605 Azabicyclo[2.2.1]Heptane Compounds as Alpha-7 Nicotinic Acetylcholine Receptor Ligands
10/27/2011	US20110263597 Substituted pyridines and pyridazines with angiogenesis inhibiting activity
10/27/2011	US20110263595 Compounds and methods for kinase modulation, and indications therefor
10/27/2011	US20110263582 Cyclic urea inhibitors of 11 b-hydroxysteroid dehydrogenase 1
10/27/2011	US20110263575 Compounds Useful as Protein Kinase Inhibitors
10/27/2011	US20110263561 Novel pyrrolidone derivatives for use as MetAP-2 inhibitors
10/27/2011	US20110263557 Compounds and compositions as modulators of gpr119 activity
10/27/2011	US20110263549 4-dimethylamino-phenyl-substituted naphthyridines, and use thereof as medicaments
10/27/2011	US20110263547 C-19 steroids for specific therapeutic uses
10/27/2011	US20110263541 Kinase inhibitors and their use as pharmaceutical agents
10/27/2011	US20110263519 Regulators of the hedgehog pathway, compositions and uses related thereto
10/27/2011	US20110263504 Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage
10/27/2011	US20110263501 Growth Hormone Conjugate with Increased Stability
10/27/2011	US20110263499 Ifbm's to promote the specific attachment of target analytes to the surface of orthopedic implants
10/27/2011	US20110263494 Nonsteroidal compounds useful as modulators of glucocorticoid receptor ap-1 and/or nf-kappab acitivity and use thereof
10/27/2011	US20110263478 Sur1 inhibitors for therapy
10/27/2011	US20110263027 Adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby
10/27/2011	US20110262568 Pharmaceutical composition for treatment of lumbar disc herniation and preparation method thereof
10/27/2011	US20110262567 Composition for treating gout, containing angelica gigas extract having a xanthine oxidase-inhibiting effect and an inflammation-inducing enzyme-inhibiting effect
10/27/2011	US20110262554 Compositions for repair of defects in osseous tissues, and methos of making the same
10/27/2011	US20110262552 Compositions Comprising Plant Extracts and Use Thereof for Treating Inflammation
10/27/2011	US20110262542 Controlled Delivery of Tetracycline Compounds and Tetracycline Derivatives
10/27/2011	US20110262541 Foam-formed collagen strand
10/27/2011	US20110262528 Pharmaceutical composition for the prevention and treatment of bone tissue resorption of various etiology
10/27/2011	US20110262516 Autologous cells on a support matrix for tissue repair
10/27/2011	US20110262511 Novel Uses
10/27/2011	US20110262502 Pulmonary delivery of 17-hydroxyprogesterone caproate (17-hpc)
10/27/2011	US20110262493 Multi-layered hydrogel constructs and associated methods
10/27/2011	US20110262484 Outer membrane vesicle prime-protein boost vaccine
10/27/2011	US20110262454 Novel anti-cd38 antibodies for the treatment of cancer
10/27/2011	US20110262449 Method for the treatment of gout or pseudogout
10/27/2011	US20110262445 Anti-il-12/il-23 antibodies
10/27/2011	US20110262433 Method for inhibiting bone resorption
10/27/2011	US20110262432 mutated netrin 4 proteins, fragments thereof and their uses as drugs
10/27/2011	US20110262422 Orally administrable dosage forms comprising angiogenin and uses thereof
10/27/2011	US20110262407 Treatment with alpha7 selective ligands
10/27/2011	US20110262404 Novel Mesenchymal Stem Cells and Bone-Forming Cells
10/27/2011	US20110262403 Method of accelerating osteogenic differentiation and composition thereof
10/27/2011	US20110262402 Therapeutic and prophylactic agents for arthritis
10/27/2011	US20110262392 Medium derived from stem cells as a pharmaceutical composition
10/27/2011	US20110262388 Novel inhibitors
10/27/2011	US20110262386 Methods of treating inflammation
10/27/2011	US20110262359 Compositions comprising enzyme-cleavable prodrugs of active agents and inhibitors thereof
10/26/2011	EP2380881A1 Novel bicyclic heterocyclic compound
10/26/2011	EP2380878A1 Cyclic compound having hetero atom
10/26/2011	EP2380877A1 Pyridine-3-carboxyamide derivative
10/26/2011	EP2380872A1 Polycationic compounds and uses thereof
10/26/2011	EP2379533A1 N-substituted saturated heterocyclic sulfone compounds with cb2 receptor agonistic activity
10/26/2011	EP2379175A1 A process for preparation of hexadecyl cis-9-tetradecenoate and hexadecyl cis-10-tetradecenoate
10/26/2011	EP2379090A1 Improved animal treatment
10/26/2011	EP2026788B1 Therapeutic combination for painful medical conditions
10/26/2011	EP2014764B1 Method of producing dry yeast containing s-adenosyl-l-methionine and composition for oral intake
10/26/2011	EP1879611B1 Insp163 polypeptides and polynucleotides for the treatment or prevention of lung cancer
10/26/2011	EP1864994B1 Par-2 agonist
10/26/2011	EP1425010B1 Substituted indoles and their use as integrin antagonists
10/26/2011	CN1662243B Pharmaceutical composition
10/26/2011	CN102227419A Anhydrate and hydrate forms of strontium ranelate
10/26/2011	CN102227409A Pyridine-3-carboxyamide derivative
10/26/2011	CN102227221A Pharmaceutical combination containing hsp90 inhibitor and mtor inhibitor

1 ... 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 ... 820